Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Pavord

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The European Respiratory Journal|June 3, 2000
Prednisone-dependent asthma: inflammatory indices in induced sputumM M Pizzichini, E Pizzichini, L Clelland, et al.
Lancet (London, England)|August 6, 1994
Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sampleJ Britton, I Pavord, K Richards, et al.
The European Respiratory Journal|May 1, 1994
Factors influencing the occurrence of airway hyperreactivity in the general population: the importance of atopy and airway calibreJ Britton, I Pavord, K Richards, et al.
Allergy|August 12, 1999
Increases in eotaxin-positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challengeK Zeibecoglou, A J Macfarlane, S Ying, et al.
Thorax|December 5, 2008
Breathing exercises for asthma: a randomised controlled trialM Thomas, R K McKinley, S Mellor, et al.
The European Respiratory Journal|November 27, 2010
Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trialS T Holgate, M Noonan, P Chanez, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 19, 2011
A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthmaN Barnes, I Pavord, A Chuchalin, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 1, 1999
Association between - 308 tumour necrosis factor promoter polymorphism and bronchial hyperreactivity in asthmaT C Li Kam Wa, A H Mansur, J Britton, et al.
Frontiers in Allergy|December 27, 2024
European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learnedD M Conti, V Backer, W Fokkens, et al.
Allergy|January 14, 2014
EAACI position statement on asthma exacerbations and severe asthmaA Custovic, S L Johnston, I Pavord, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The European Respiratory Journal|June 3, 2000
Prednisone-dependent asthma: inflammatory indices in induced sputumM M Pizzichini, E Pizzichini, L Clelland, et al.
Lancet (London, England)|August 6, 1994
Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sampleJ Britton, I Pavord, K Richards, et al.
The European Respiratory Journal|May 1, 1994
Factors influencing the occurrence of airway hyperreactivity in the general population: the importance of atopy and airway calibreJ Britton, I Pavord, K Richards, et al.
Allergy|August 12, 1999
Increases in eotaxin-positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challengeK Zeibecoglou, A J Macfarlane, S Ying, et al.
Thorax|December 5, 2008
Breathing exercises for asthma: a randomised controlled trialM Thomas, R K McKinley, S Mellor, et al.
The European Respiratory Journal|November 27, 2010
Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trialS T Holgate, M Noonan, P Chanez, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 19, 2011
A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthmaN Barnes, I Pavord, A Chuchalin, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 1, 1999
Association between - 308 tumour necrosis factor promoter polymorphism and bronchial hyperreactivity in asthmaT C Li Kam Wa, A H Mansur, J Britton, et al.
Frontiers in Allergy|December 27, 2024
European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learnedD M Conti, V Backer, W Fokkens, et al.
Allergy|January 14, 2014
EAACI position statement on asthma exacerbations and severe asthmaA Custovic, S L Johnston, I Pavord, et al.
Pageof 4